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Objectives: Reducing sexually transmitted infections (STI) and teenage pregnancy through effective health education is a high priority for health policy. Behavioral interventions which teach skills to
practice safer sex may reduce the incidence of STIs. We evaluated the cost-effectiveness of school-based behavioral interventions in young people.
Methods: We developed an economic model to estimate the total number of STI cases averted, consequent gain in health related quality of life (HRQoL) and savings in medical costs, based on
changes in sexual behavior. The parameters for the model were derived from a systematic literature search on the intervention effectiveness, epidemiology of STIs, sexual behavior and lifestyles,
HRQoL and health service costs.
Results: The costs of providing teacher-led and peer-led behavioral interventions were €5.16 and €18 per pupil, respectively. For a cohort of 1000 boys and 1000 girls aged 15 years, the model
estimated that the behavioral interventions would avert two STI cases and save 0.35 Quality Adjusted Life Years (QALYs). Compared to standard education, the incremental cost-effectiveness of the
teacher-led and peer-led interventions was €24,268 and €96,938 per QALY gained, respectively.
Conclusions: School-based behavioral interventions which provide information and teach young people sexual health skills can bring about improvements in knowledge and increased self-efficacy,
though these may be limited in terms of impact on sexual behavior. There was uncertainty around the results due to the limited effect of the intervention on behavioral outcomes and paucity of data
for other input parameters.
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Rates of sexually transmitted infections (STIs) are continuing
to rise in the many countries, particularly among young peo-
ple (10). If undiagnosed and untreated, STIs can lead to se-
rious long-term complications, such as infertility and pelvic
inflammatory disease (PID), and, in the case of human immun-
odeficiency virus (HIV), mortality. The rise in STIs is in part
due to greater uptake of testing, which is identifying more in-
fections, but also continuing unsafe sexual behavior in young
people (10;13). Often these young people lack the skills and
confidence to negotiate safer sex.
The impact of increases in the incidence and prevalence
of STIs over recent years has placed great demand on health
services and the prevention of STIs and teenage pregnancy is
currently a high priority for health policy. To reduce STIs, ef-
fective health education strategies need to be developed and
implemented to provide knowledge for and change young peo-
ples’ sexual behavior.
Behavioral interventions to prevent STIs are often provided
in schools and colleges as part of the curriculum, for example
in the United Kingdom, these are provided during Sex and Re-
lationship Education (SRE) lessons. There is variability in the
topics covered, the format of the lessons, and the staff used to
deliver them. Some schools primarily provide factual informa-
tion, whereas others supplement this with interactive learning,
such as role play, condom use demonstrations, and educational
theater, sometimes with input from outside agencies, for exam-
ple health promotion services. The objective of SRE is to help
and support young people through their physical, emotional, and
moral development and to enable them to make informed deci-
sions about their lives. However, there is uncertainty and some-
times controversy about how and when sex education should be
provided.
Interventions to prevent STIs in young people should be
based upon sound evidence. In addition, the costs of such
interventions and the gains to health, in terms of the in-
fections averted, associated gains in health-related quality of
life (HRQoL), and lives saved, should be assessed. The cost-
effectiveness of an intervention provides a measure of its value
for money, and is part of the evidence used by decision makers.
There is a dearth of evidence for the cost-effectiveness of some
types of health promotion, particularly social interventions in
schools, although decisionmakers need such evidence to inform
the allocation of scarce resources. The objective of this study is
to assess the cost-effectiveness of school-based behavioral in-
terventions for the prevention of STIs in young people through
the development of an economic model.
METHODS
Cost-Effectiveness Analysis
The cost-effectiveness of two types of school-based behavioral
interventions were assessed: teacher-led and peer-led. Both
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interventions provide factual information about STIs in ad-
dition to the teaching of skills associated with the practice
of safer sex. These two interventions were considered to be
broadly representative of studies of the effectiveness of behav-
ioral interventions to prevent STIs that were included in our
systematic review (22). The teacher-led intervention comprised
twenty sessions taking place over a 2-year period (10 sessions
at age 13–14 years, and 10 sessions at age 14–15 years). The
intervention was intended to reduce unsafe sex and unwanted
pregnancies and improve the quality of sexual relationships. It
involved active learning (small group work and games), infor-
mation leaflets on sexual health, and development of skills, pri-
marily through the use of interactive video and role playing. The
peer-led intervention comprised three sessions led by peer ed-
ucators lasting 1 hour each, over one school term. The sessions
covered relationships, sexually transmitted infections, and use
of condoms and contraception. They were designed to be infor-
mal using small group work, role plays, and condom use skills
demonstrations.
The comparator for both of these interventionswas standard
sexual health education, which is generally provided by teach-
ers in British schools as part of the SRE curriculum. Standard
sexual health education generally provides basic information on
STIs and sexual health, but does not necessarily teach safer sex
negotiation skills. It is, therefore, the teaching of safer sex skills
and other broader activities that distinguishes the behavioral
intervention from standard education.
The model was constructed in Microsoft Excel according
to standard methods (18). Only direct National Health Service
(NHS) and Personal Social Services (PSS) costs were included;
hence, the model was from the perspective of the UK NHS and
PSS. In the base case analysis, a cohort of young people aged
15 years old receive the teacher-led intervention. The model
estimates the costs and benefits from averted STI cases for the
intervention and, hence, the cost-effectiveness of the interven-
tion compared with standard sexual health education.
We adapted a previously developed Bernoulli statistical
model (28) as it estimates the effect of changes in sexual be-
havior in terms of STIs averted. The Bernoulli model of HIV
transmission is a cumulative probability equation that describes
the probability of HIV infection based upon HIV prevalence
(π ), single act transmission probability (α), condom effective-
ness (e) and condom use (f), number of sexual episodes (n),
and number of sexual partners (m). For example, the estimated
probability of an uninfected person becoming infected is P,
P = 1 − {(1 − π ) + π |1 − α(1 − ef )|n}m .
The model estimates the probability of becoming in-
fected for the intervention and comparator groups according
to changes in parameters that may be affected by the interven-
tion, that is, condom use, number of sexual partners, number of
sexual episodes. The number of cases averted is estimated by
multiplying the results by the number of people who receive the
intervention. These cases averted would have, in turn, infected
further individuals, that is, through secondary transmission. The
number of cases averted through secondary transmission is es-
timated by multiplying the risk of becoming infected by the
number of cases averted through primary transmission.
The model estimates the number of cases averted for HIV,
chlamydia, gonorrhea, and genital warts, according to the risk
of infection and the proportion of sexually active individuals
who receive the intervention. For each STI case averted, there
is a HRQoL loss and resource use cost associated due to com-
plications, such as PID or infertility. The data and assumptions
used to derive the model parameters are described briefly below
and in more detail elsewhere (22).
The total number of STI cases averted, consequent quality-
adjusted life-year (QALY) gain, cost of the intervention, and
the saving in medical costs is estimated for males and females
for one year. Thus the cost-effectiveness is calculated,
Cost effectiveness = Cost of intervention - Saving in medical costs
QALYs gained
.
This outcomemeasure gives a guide to whether the intervention
is good value for money for healthcare decision makers. For the
UK NHS, an intervention with a cost-effectiveness ratio less
than £30,000 (€36,000) per QALY is generally considered to
be cost-effective.
Parameters Used in the Model
The parameters used in the model were derived from a range of
sources providing epidemiological and quality of life data and
are described in the following section. To identify data to pop-
ulate the model, systematic searches were conducted to locate
studies on the natural history and epidemiology of STIs, sexual
behavior and lifestyles of the target population, HRQoL, and
costs. Web sites of relevant organizations were also searched
and contact was made with experts in the field to identify data.
The baseline clinical data were estimated from administrative
databases for the United Kingdom, and prospective studies.
The HRQoL data have been taken from previous utility stud-
ies using validated tools for groups of patients who developed
STI complications. Costs were derived from published studies
(where available), and from national and local NHS unit costs.
The quality of data used for the model varied. Generally, there
were few data for children younger than 18 years old. Where
there were no data, assumptions were made from existing data.
The parameters used in the model are shown in Table 1.
The prevalence of STIs in young people was taken from the
National Chlamydia Screening program (5;20) and data from
the Health Protection Agency (9;10). We estimated the unit
cost and QALY loss per case of STI, based on the prevalence of
complications of STIs.
In the model, the intervention effects last for 1 year,
on the basis that the majority of the trials included in our
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Table 1. Data Parameters Used in the Cost-Effectiveness Model
Prevalence of STIs (5) (20) (9) (10) STI complications’ cost and HRQoL a
< 16 years old > 16 years old Medical costs, € QALY loss
Male Female Male Female (1) (3) (17) (23) (12) (4) (17)
Chlamydia 1.5% 7.5% 10% 12.5% 904.04 0.27
Gonorrhea 0.03% 0.16% 1.25% 1.3% 904.04 0.27
Genital warts 0.1% 0.65% 0.53% 1.4% 675.13 0.238
HIV 0.13% 0.06% 0.26% 0.12% 490,385 8.4
a Cost and QALY loss shown for STI complications per case of STI for females.
STI, sexually transmitted infection; HRQoL, health-related quality of life; QALY, quality-adjusted life-year; HIV, human immunodeficiency virus.
systematic review of effectiveness assessed outcomes up to 1
year. The effectiveness of the behavioral intervention on con-
dom use was derived through a meta-analysis of the studies of
behavioral interventions included in our systematic review and
produced a pooled risk ratio (RR) of 1.05 (95 percent confi-
dence interval, 0.92 to 1.20) in favor of the behavioral inter-
vention (versus standard education) (22). The pooled RR is not
statistically significant, so caution is advised when interpreting
these results.
The data used to derive STI transmission probabilities were
primarily based on case series. Quinn et al. determined the fre-
quency of Chlamydia trachomatis genital infection within sex-
ual partnerships (19). In the study, chlamydia was transmitted
between partners in 68 percent of the couples during a 4-year
period. The per episode chlamydia transmission probability was
estimated by assuming that the infection would be transmitted
within 10 sexual episodes per relationship and resulted in a
per-episode transmission probability of 0.11. Using the same
method, the per-episode transmission probability was estimated
to be 0.07 for gonorrhea (21) and 0.1 for genital warts (11). We
derived the transmission probability for HIV from a literature
review on the risk of HIV transmission following an exposure
from a known HIV-positive individual (8).
Data on HRQoL associated with STI complications were
derived from studies for HIV (25), for chlamydia and gonorrhea
(12;23), and for genital warts and cervical cancer (4). These
data were for the prevalence of the conditions, the duration
of the symptoms, and the HRQoL loss associated with each
complication.
The cross-national Health Behavior in School-aged Chil-
dren (HBSC) survey (29) reported the proportion of sexually
active young people in England (males 36 percent; females
40 percent), and their condom use at last intercourse (males
69 percent; females 71 percent). The number of sexual partners
that young people have has been estimated, as 2.1 per year for
male and 2 per year for females, from a multi-purpose survey
with approximately 1,200 adults (aged 16 or over) in private
households in Great Britain each month (14). The UK National
Survey of Sexual Attitudes and Lifestyles (NATSAL) reported
that the number of occasions of heterosexual sex in the past
4 weeks for 16- to 24-year-olds among respondents who had
one or more heterosexual partners in the year before interview
was 6.9 (SD 9.1) (13). Because data on sexual activity in the
under 16 age group are lacking we assumed lower sexual activ-
ity for the under 16-year-old age group and that it would be a
quarter of the rate seen in the 16- to 24-year-old group, that is,
1.7 episodes per month.
As the analysis reflects an NHS perspective, it uses UK-
specific resource use and costing data where available. Cost
data were obtained from several primary and secondary sources.
Unit costs for the complications of STIs are shown in Table 1.
Adams et al. evaluated the cost-effectiveness of the National
Chlamydia Screening Program in England (1), estimating the
cost of complications based on diagnosis and treatment. The
cost of HIV treatment was derived from a cost-effectiveness
study for adults with HIV in England of highly active antiretro-
viral therapy (HAART) compared with two nucleoside reverse
transcriptase inhibitors (NRTIs) (17). We updated their analysis
to reflect changes in mortality, discount rates, and healthcare
costs and derived that individuals with HIV would have 8.4
fewer QALYs than an uninfected individual, with a lifetime dis-
counted medical cost of €490,389. Individuals infected with
human papillomavirus types 16 and 18 are at risk of cervical
cancer. The first year cost of cervical cancer was estimated to
be €12,557 per patient (31), which includes all treatment costs.
The cost for treating genital warts was approximately €266 per
case (15).
The teacher-led intervention was based upon a Scot-
tish study (the SHARE trial) (30), and comprised a 20 ses-
sion classroom-based program over 2 years (10 sessions at
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Table 2. Base Case Results for the Teacher-Led Behavioral Intervention Compared to Standard Sex Education
HIV Chlamydia Gonorrhea Genital warts
Male Female Male Female Male Female Male Female Pregnancy Total
Cases control 0.002 0.007 7.33 10.34 0.13 1.03 0.96 0.82 20.71
Cases intervention 0.001 0.006 6.57 9.22 0.11 0.92 0.90 0.77 18.5
Cases averted, total 0.000 0.000 0.76 1.12 0.01 0.11 0.06 0.05 0.05 2.1
QALY gained 0.00 0.00 0.00 0.30 0.00 0.03 0.00 0.01 0.00 0.35
Total medical costs averted, € 46 221 6 1013 0 101 16 35 308 1745
QALY, quality-adjusted life-year; HIV, human immunodeficiency virus.
age 13–14 years, and 10 at age 14–15 years). The peer-led
classroom intervention was based upon an English trial (the
RIPPLE trial) (24) and comprised three sessions during one
term. The costs of teacher-led and peer-led sexual education
interventions are based upon the resources used in the SHARE
(30) and RIPPLE trials (24). Contact was made with both the
SHARE and RIPPLE research teams to request data on costs
and resources. Limited data were available from the teams, so
most of the resources were estimated by systematically extract-
ing data from the study publications. We updated the costs
to present day values using the NHS multiplier for Hospital
& Community Health Services (7). This method converts a
cost in a base year to the current year by multiplying the base
cost by an index that reflects changes in costs between these
years. The training costs for standard sex education were as-
sumed to be minimal as the majority of the training would take
place in house, for example during In-Service Training (INSET)
days.
For the teacher-led intervention, we estimated resources
based on the SHARE trial, where the teachers were taught in
groups of thirteen during a 5-day training course run by a health
promotion practitioner. For the sixty-nine teachers in the thirteen
schools who took part in the trial, the total updated cost of the
teacher training was €108,193 and 4,197 pupils received the
program. We assumed that all teachers that taught SRE would
receive training andwould be retrained every 5 years. The yearly
cost for training was €5.16 per pupil who received the program.
For the peer-led intervention, we estimated the resources
based on the RIPPLE trial where there was no training for
the teachers involved, only for peer educators. The RIPPLE
trial included 4,063 pupils, 463 peer educators, and fourteen
schools. The training was undertaken in groups of twelve peer
educators per training session over a 2-day intensive course led
by a health promotion practitioner. Peer educatorswere assumed
to only teach sex education for 1 year, following which a new
cohort of educators will be recruited and trained. The total costs
for the training in the RIPPLE trial was estimated to be €73,154
or €18 per pupil who received the program.
Table 3. Summary Results for the Teacher-Led and Peer-Led Behavioral
Interventions Compared to Standard Sex Education
Teacher-led Peer-led
Total cost of intervention, € 10,320 36,000
Total medical costs averted, € 1,745 1745
Net additional cost, € 8,575 34,255
Cost per case averted (all STI), € 4,058 16,210
Incremental cost per QALY gained, € 24,268 96,938
STI, sexually transmitted infection; QALY, quality-adjusted life-year.
RESULTS
The model was run with the inputs shown in Table 1 for a
cohort of 1,000 boys and 1,000 girls aged 15 years old. In the
base case analysis, the costs from the teacher-led behavioral
intervention (SHARE) were used and the results are shown in
Table 2. These indicate that the teacher-led intervention would
have a net additional cost of €8,575 and avert an extra two STI
cases with a corresponding quality of life gain of 0.35 QALY
compared with standard sex education. This corresponds to
an incremental cost-effectiveness ratio (ICER) of €24,268 per
QALY gained. The results indicate that most of the STI cases
averted are of chlamydia (because this was the most prevalent
STI) and the largest QALY gain would be for females who avoid
infection with chlamydia.
Using the same intervention effect estimate for the peer-led
behavioral intervention (RIPPLE), results in the same health
gains, in terms of cases averted and QALYs gained, but at a
higher cost corresponding to an ICER of €96,938 per QALY
gained (Table 3). The peer-led behavioral intervention is less
cost-effective than the teacher-led intervention compared with
standard sex education. This is due to the peer-led behavioral
intervention being much expensive than the teacher-led inter-
vention, due to the need for more frequent training of the peer
educators.
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Table 4. Sensitivity Analyses for the STI Model (Teacher-Led Behavioral Intervention Compared to Standard Sex Education)
Inputs ICER, € / QALY
Variable Base case Low High Low High Range, €
IE Condom use (RR) 1.05 0.92 1.2 −23,190 2,364 N/A
Transmission probability 11a 3a 20a 85,669 16,068 69,601
IE Number of sex partners 1 0.95 1.05 13,387 69,976 56,588
Tubal infertility disutility 0.76 0.61 0.91 51,898 15,836 36,061
IE Sex episodes per partner 1 0.95 1.05 15,521 45,314 29,794
BC Number of sexual partners 2 1.5 4 36,743 7,170 29,573
STI prevalence 7.5ab 5.3ab 9.8ab 34,562 12,996 21,566
Proportion sexually active 36 25 45 42,180 21,232 20,948
BC Sex episodes per partner 10 6 14 38,345 18,785 19,560
Intervention cost, € 5.16 3.6 6.72 15,438 33,097 17,659
QALY loss per STI case 0.27a 0.19a 0.35a 34,668 18,667 16,001
a Values shown for chlamydia. Parameters for other STIs were altered by the same magnitude.
b Values shown for females
BC base case; IE intervention effect; STI, sexually transmitted infection; QALY, quality-adjusted life-year.
Sensitivity Analysis
The parameters in the economic model were varied in a series
of sensitivity analyses of the base case analysis and the results
are shown in Table 4. Where possible, the parameters were
varied according to the ranges of the confidence intervals of
these parameters, otherwise a suitable range was chosen. Pa-
rameter values for all the STIs were altered by the same magni-
tude but for simplicity only the input parameters for chlamydia
are shown in Table 4. The sensitivity results are nonlinear, as
seen for the parameter for the number of sex episodes per part-
ner (episodes varied from 6 to 14). In this case, the ICER for
6 and 14 sex episodes per partner is €38,345 and €18,785, re-
spectively, compared with the base case of €24,268.The results
were most sensitive to the intervention effect, the transmission
probability, and the number of sexual partners. The base case
analysis assumes that the intervention effects last for 1 year. It
may be that the intervention effects last for more than 1 year.
In the case of the intervention effect lasting 2 years, the ICER
decreases to €7,170 per QALY gained.
A further scenario analysis assessed the effect of the inter-
vention in older teenagers (aged 16–19 years). In this group,
there are more sexually active individuals (male, 56 percent; fe-
males, 66 percent)(14), who have more sexual episodes per
month (6.9 percent) (13) than younger teenagers. However,
condom use for sexually active individuals was lower (male,
55 percent, female, 47 percent) (14). The results from the model
showed that, in this age group, there are more STI cases averted,
QALYs gained, and medical costs averted that in the younger
age group. The ICER for this age group is €13,994 per QALY
gained.
We also explored the uncertainty around themodel results in
more detail using probabilistic sensitivity analyses. The model
was run for 1,000 iterations with input values sampled from
probability distributions. The parameters were varied accord-
ing to the ranges used in the deterministic sensitivity analysis.
In this analysis, the teacher-led intervention had an ICER be-
tween €0 and €36,000 per QALY for 48 percent of iterations
(Figure 1), more than €36,000 per QALY for 28 percent of
iterations. For 24 percent of iterations, the intervention was
associated with a QALY loss. The peer-led intervention had a
corresponding lower likelihood of being cost-effectiveness,with
an ICER between €0 and €36,000 per QALY for 16 percent of
iterations.
DISCUSSION
The results of this economic evaluation indicate that with cur-
rent evidence, behavioral interventions are likely to lead to a
small reduction in risky sexual behavior, which has a corre-
sponding small health benefit, due to avoiding STIs. These in-
terventions are relatively low cost; therefore, if these benefits
are sustained they are likely to be good value for money, ac-
cording to NICE criteria, whereby the cost-effectiveness is in
the range €24,000–€36,000 (or lower) per QALY gained (18).
However, there is large uncertainty around the parameter
inputs, and hence also around the model results, which make it
difficult to draw firm conclusions.
Both the SHARE and RIPPLE studies concluded that the
interventions had not been wholly successful in encouraging
safer sexual behavior. The authors of both trials discuss the
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Figure 1. Cost-effectiveness acceptability curves of the PSA results for 1,000 iterations for the teacher and peer led interventions versus standard care. QALY, quality-adjusted life-year.
likely reasons for this. Wight et al. concluded that, for some
young people, the skills would not be put into practice until
they had begun a sexual relationship, by which time the skills
would likely be harder to recall (30). The results from our model
also suggest that interventions would be better value for money
if conducted at a later age.
The cost-effectiveness of school-based interventions has
previously been evaluated for “Safer Choices,” a 2-year, theory-
based, multi-component HIV/STI prevention intervention in the
United States (6;26). The conclusions from these evaluations
varied widely: one study (6) found the intervention was not
cost-effective with a cost per STI case averted > $39 million.
In contrast, the other (26) found the same intervention was
cost saving. The difference in the results between these two
studies may be partly explained by the fact that Wang et al.
(26) included the effects of the intervention on other STIs and
unintended pregnancy; while these effects were not included by
Cohen et al. (6)
The current study incorporated the impact of changes in
HRQoL to individuals from the STIs to present the results in
terms of cost per QALYs gained, which are commonly used
by health decision makers (18). Few studies that have esti-
mated the cost-effectiveness of interventions to prevent STIs
have used estimates of QALYs (2). Rather, they have used other
outcome measures such as cost per major outcome averted or
cost per case avoided (16;26), which makes them more diffi-
cult to compare with other health interventions, and involves
making assumptions such as assuming that all STIs have equal
health consequences, which is unlikely to be the case.
The evaluation of public health and health promotion
interventions presents particular methodological challenges
compared with the evaluation of clinical interventions (27).
Decision makers, such as NICE, prefer evidence comparing
the relevant alternatives to come from randomized controlled
trials (RCTs) where available. However, there are fewer con-
trolled trials of public health interventions, and these tend to
be heterogeneous, of variable methodological quality and with
short follow-up. Economic evaluation requires estimation of
long-term outcomes, with health outcomes typically measured
in QALYs, which are often difficult to quantify within a public
health context. Public health interventions are often wide rang-
ing with the cost and benefits associated with an intervention
falling on many parts of the public sector (e.g. education and
health services). Finally, the data used to build economic mod-
els are often scarce and several assumptions may have to be
made.
Our economic evaluation is one of the few published exam-
ples of an assessment of the cost-effectiveness of school-based
behavioral interventions, particularly in the United Kingdom.
It was informed by a systematic review of RCTs of the ef-
fectiveness of the interventions, systematic review of previous
cost-effectiveness studies, and systematic searches for the in-
put parameter data. Despite these strengths, it is subject to the
following limitations. Although the results from the systematic
review of effectiveness showed that these programs can bring
about improvements in knowledge, and increased self-efficacy,
the meta-analysis did not show a statistically significant inter-
vention effect for behavioral outcomes. However from a health
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economic framework, Bayesian statistical techniques such as
probabilistic sensitivity analysis are useful to describe the un-
certainty around the results. In this case, we have used the best
available data and shown the probability that the intervention
will be beneficial and / or cost-effective compared with standard
sex education.
Furthermore, although teacher-training behavioral inter-
ventions and peer-led behavioral interventions are both com-
pared with standard sexual health education, there is no direct
evidence comparing peer-led and teacher-led behavioral inter-
ventions. The differences in the results are due to the difference
in the costs of the two interventions, whereby the teacher-led
behavioral intervention was cheaper due to the need for less
frequent training. We have assumed the same effect from both
interventions (as the intervention effect has been derived from a
meta-analysis for behavioral interventions versus standard sex
education).
For many of the parameters for the economic evaluation,
there were no available data for the <16-year-old age group
and we have had to make assumptions to extrapolate data from
older teenagers group. In particular, data on the sexual behavior
of under-16s is needed. Often data are presented for the 18- to
25-year-old age group in national surveys, and we recommend
that the age groups used are extended.
CONCLUSION
School-based behavioral interventions which provide informa-
tion and teach young people sexual health skills can bring
about improvements in knowledge and increased self-efficacy,
although these may be limited in terms of impact on sexual be-
havior. These interventions have been evaluated using an eco-
nomicmodel that describes the cost and benefits associatedwith
reductions in STIs due to improved sexual behavior. There is
uncertainty around the results of our economic evaluation due
to the uncertainty around the effect of the intervention on sexual
behavioral outcomes. The model results were most sensitive to
changes in parameter values for the intervention effect and the
transmission probability of STIs. Teacher-led interventions are
likely to be cheaper than peer-led interventions due to less fre-
quent retraining. Further economic evaluation, integrated into
primary evaluation, is needed.
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